The RCG team welcomes two new members
Laurane Mangé is a Master student in Bioinformatics and Modelling from the National Institute of Applied Sciences of Lyon (INSA Lyon). She will be working for 6 months with Nicolas Alcala on the genomic evolution of tumor phenotypes and on single-cell transcriptomics of malignant pleural mesothelioma. Maike Morrison is a PhD student in Biology from
The RCG team marks Rare Disease Day 2023 with a new video
In a new video to mark Rare Disease Day, Matthieu Foll, Alexandra Sexton Ouates and Emilie Mathian from the RCG team at IARC present one aspect of the lungNENomics project, which aims to improve the diagnosis and clinical management of lung neuroendocrine tumours using a combination of AI and genomic techniques. Read the IARC press
Neuroendocrine Tumor Research Foundation investigator award to Matthieu Foll
Scientists from the RCG team are among the recipients of research grants awarded by the Neuroendocrine Tumor Research Foundation (NETRF), announced on 16 February. Matthieu Foll, Lynnette Fernandez-Cuesta, and their co-investigators in the “Reconciling lung carcinoids histopathological and molecular classifications” project were chosen to receive the funding through a competitive and rigorous peer-review process. This
Oral presentation at the 18th edition of the International Conference on Theory and Applications of Computer Vision (Visapp 2023)
Emilie Mathian had an amazing time at the 18th edition of the International Conference on Theory and Applications of Computer Vision in Lisbon, Portugal (Visapp 2023). The conference was an opportunity to learn about theoretical and applicative advances in computer vision and robotics from the best researchers in the field. Emilie presented her paper entitled
The RCG team welcomes Dr. Gabrielle Drevet
Dr. Gabrielle Drevet is a thoracic surgeon at the Lyon university hospital centre (HCL – service de chirurgie thoracique videothoracoscopie et transplantation pulmonaire). She is starting a PhD co-supervised by Dr. Matthieu Foll and Dr. Jean Michel-Maury (HCL), exploring the molecular heterogeneity of pleural tumors.
Oral presentation at the 2022 NETRF Symposium
Matthieu Foll presented the advances of the lungNENomics project with an oral talk entitled “Characterising Aggressive Pulmonary Carcinoids Through Integrative Omics Analysis Within the lungNENomics Project” during the 2022 Neuroendocrine Tumor Research Foundation (NETRF) Symposium, Boston, USA (November 17-18). This work has been funded by a NETRF 2019 investigator award to Lynnette Fernandez-Cuesta.
Poster presentation at the 5th International Cancer Symposium of the Lyon Cancer Research Center
Dr. Alexandra Sexton and Emilie Mathian presented two posters at the 5th International Cancer Symposium of the Lyon Cancer Research Center (CRCL), on mesothelioma and neuroendocrine carcoids of the lung, respectively. Alexandra’s poster entitled « Disentangling heterogeneity of malignant pleural mesothelioma through deep integrative omics analyses », presents our paper of the same name recently accepted in
Invited keynote lecture at the 12th European Meeting on Molecular Diagnostics
Matthieu Foll was invited to give a keynote lecture at 12th European Meeting on Molecular Diagnostics, Noordwijk, Netherland (October 12-14) entitled “Multi-omics characterization of heterogeneous tumors”.
Talk on the ecology and evolution of rare thoracic tumors at Stanford University
Nicolas Alcala was invited to give the keynote lecture at Stanford’s Evolgenome seminar series for the 10-year anniversary of Stanford’s Center for Evolutionary and Human Genomics (CEHG). He focused on the team’s work on quantifying tumor evolutionary forces using organoid experimental models and on identifying tumor ecological strategies from multi-omic data. You can see a
IASLC 2022 World Conference on Lung Cancer
This August the RCG team headed to Vienna to present the LungNENomics and MESOMICS projects at the World Conference on Lung Cancer (WCLC). Nicolas Alcala gave talks on the evolution of lung neuroendocrine tumours (LNETs), and understanding inter-patient heterogeneity in malignant pleural mesothelioma, whilst Alexandra Sexton-Oates and Emilie Matthian presented their work on multi-omic characterisation